Skip Nav Destination
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Issue Archive
September 22 2011
In this Issue
Table of Contents
Inside Blood
Plenary Paper
PLENARY PAPER
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube,Masao Nakagawa,Shinobu Tsuzuki,Ichiro Takeuchi,Keiichiro Honma,Yasuhiro Nakashima,Norio Shimizu,Young-Hyeh Ko,Yasuo Morishima,Koichi Ohshima,Shigeo Nakamura,Masao Seto
Perspectives
Review Article
Hematopoiesis and Stem Cells
Immunobiology
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders
Clinical Trials & Observations
Stefania Piconi,Serena Parisotto,Giuliano Rizzardini,Simone Passerini,Roberta Terzi,Barbara Argenteri,Paola Meraviglia,Amedeo Capetti,Mara Biasin,Daria Trabattoni,Mario Clerici
Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection
R. Keith Reeves,Premeela A. Rajakumar,Tristan I. Evans,Michelle Connole,Jacqueline Gillis,Fay E. Wong,Yury V. Kuzmichev,Angela Carville,R. Paul Johnson
Lymphoid Neoplasia
Myeloid Neoplasia
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Clinical Trials & Observations
Bengt Simonsson,Tobias Gedde-Dahl,Berit Markevärn,Kari Remes,Jesper Stentoft,Anders Almqvist,Mats Björeman,Max Flogegård,Perttu Koskenvesa,Anders Lindblom,Claes Malm,Satu Mustjoki,Kristina Myhr-Eriksson,Lotta Ohm,Anu Räsänen,Marjatta Sinisalo,Anders Själander,Ulla Strömberg,Ole Weiss Bjerrum,Hans Ehrencrona,Franz Gruber,Veli Kairisto,Karin Olsson,Fredrik Sandin,Arnon Nagler,Johan Lanng Nielsen,Henrik Hjorth-Hansen,Kimmo Porkka,for the Nordic CML Study Group
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti,Loredana Ruggeri,Alessandra D'Addio,Andrea Bontadini,Elisa Dan,Maria Rosa Motta,Sara Trabanelli,Valeria Giudice,Elena Urbani,Giovanni Martinelli,Stefania Paolini,Fiorenza Fruet,Alessandro Isidori,Sarah Parisi,Giuseppe Bandini,Michele Baccarani,Andrea Velardi,Roberto M. Lemoli
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
Florian Kuchenbauer,Sarah M. Mah,Michael Heuser,Andrew McPherson,Jens Rüschmann,Arefeh Rouhi,Tobias Berg,Lars Bullinger,Bob Argiropoulos,Ryan D. Morin,David Lai,Daniel T. Starczynowski,Aly Karsan,Connie J. Eaves,Akira Watahiki,Yuzhuo Wang,Samuel A. Aparicio,Arnold Ganser,Jürgen Krauter,Hartmut Döhner,Konstanze Döhner,Marco A. Marra,Fernando D. Camargo,Lars Palmqvist,Christian Buske,R. Keith Humphries
Phagocytes, Granulocytes, and Myelopoiesis
TH1, TH2, and TH17 cells instruct monocytes to differentiate into specialized dendritic cell subsets
Michael N. Alonso,Michael T. Wong,Angela L. Zhang,Daniel Winer,Megan M. Suhoski,Lorna L. Tolentino,Juliana Gaitan,Matthew G. Davidson,Tiffany H. Kung,David M. Galel,Kari C. Nadeau,Jinah Kim,Paul J. Utz,Kalle Söderström,Edgar G. Engleman
Platelets and Thrombopoiesis
Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression
Nauder Faraday,Lisa R. Yanek,Xiao Ping Yang,Rasika Mathias,J. Enrique Herrera-Galeano,Bhoom Suktitipat,Rehan Qayyum,Andrew D. Johnson,Ming-Huei Chen,Geoffrey H. Tofler,Ingo Ruczinski,Alan D. Friedman,Arnaldur Gylfason,Unnur Thorsteinsdottir,Paul F. Bray,Christopher J. O'Donnell,Diane M. Becker,Lewis C. Becker
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
Transplantation
Type I-IFNs control GVHD and GVL responses after transplantation
Renee J. Robb,Ellen Kreijveld,Rachel D. Kuns,Yana A. Wilson,Stuart D. Olver,Alistair L. J. Don,Neil C. Raffelt,Nicole A. De Weerd,Katie E. Lineburg,Antiopi Varelias,Kate A. Markey,Motoko Koyama,Andrew D. Clouston,Paul J. Hertzog,Kelli P. A. MacDonald,Geoffrey R. Hill
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Clinical Trials & Observations
Giuseppe Visani,Lara Malerba,Pietro Maria Stefani,Saveria Capria,Piero Galieni,Francesco Gaudio,Giorgina Specchia,Giovanna Meloni,Filippo Gherlinzoni,Claudio Giardini,Sadia Falcioni,Francesca Cuberli,Marco Gobbi,Barbara Sarina,Armando Santoro,Felicetto Ferrara,Marco Rocchi,Enrique M. Ocio,Maria Dolores Caballero,Alessandro Isidori
Vascular Biology
Correspondence
Other Departments
-
Cover Image
Cover Image
Clearance of circulating activated platelets by leukocytes in polycythemia vera and essential thrombocythemia is a hallmark of the disease. In this image, a representative electron micrograph from a patient with polycythemia vera, a neutrophil is shown engulfing a whole platelet within a phagocytic vacuole. See Figure 1 in article by Maugeri et al on page 3359.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals